Smart Drug Targeting for Tumor Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 1918
Special Issue Editor
Interests: nanomedicine; nanotechnology; nanoparticles; biomaterials; nano/microparticle technologies; drug delivery systems; membrane clocked nanoparticle; exosome; micelle; liposome; sustained release; PLGA nanoparticle
Special Issue Information
Dear Colleagues,
Smart drug targeting for tumor therapy represents a promising approach that seeks to enhance the efficacy of cancer treatment while minimizing harm to healthy tissues. This field is rapidly advancing, utilizing nanotechnology and advanced drug delivery systems to selectively transport therapeutic agents to tumor cells. Researchers aim to enhance treatment effectiveness, diminish side effects, and overcome drug resistance in cancer therapy through active and passive targeting mechanisms and strategies for stimuli-responsive drug release. The continuous progress in this area holds significant potential for the future development of more efficient and personalized cancer treatments.
This Special Issue of Pharmaceutics aims to publish research and review papers encompassing recent developments and findings on all topics related to smart drug targeting for tumor therapy. Therefore, this issue covers all various practical aspects of drug targets for cancer therapy, but is not limited to including novel materials for targeting or developing drug delivery systems such as membrane-based, micelle, exosome-based, liposome, or polymeric nanoparticles, as well as the incorporation of stimuli-responsive drug release systems.
Dr. Amalendu P. Ranjan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicine
- nanotechnology
- nanoparticles
- biomaterials
- nano/microparticle technologies
- drug delivery systems
- membrane clocked nanoparticle
- exosome
- micelle
- liposome
- sustained release
- PLGA nanoparticle
